Fig. 1From: The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe diseasePercentages for each genetic variant and each intronic variant within the total population. 1173 (55.8%) patients had genetic variants identified by the panelBack to article page